Hugel, Officially Enters Malaysian Market with Toxin Product Letybo

[Financial News] Hugel announced on the 11th that it officially launched the botulinum toxin product 'Letybo' in Malaysia, an emerging market for medical aesthetics in Southeast Asia.
Hugel participated in AMSC, Malaysia's largest medical aesthetics conference, on the 6th and 7th, and showcased Letybo.
At this event, Konstantin Frank, a key opinion leader (KOL) for Letybo in Europe, attended as a speaker and shared clinical strategies to enhance the precision of Letybo's treatment effects and the completeness of treatment results.
On the 8th, a brand launch event and hands-on workshop were held simultaneously at The Zenith Hotel in Kuantan, Malaysia, inviting about 100 local medical professionals. The workshop was composed of an educational program centered on toxin treatment methods that combine anatomical understanding and clinical experience.
This event was conducted in collaboration with Hugel's local Malaysian partner, Venusys. Venusys is a medical aesthetics product distribution company based in Malaysia and Singapore, maintaining partnerships with various global brands.
A Hugel representative stated, "Hugel plans to continue providing customized educational programs to enhance trust with local Malaysian medical professionals based on strategic collaboration with our partner," adding, "Through this, we aim to strengthen the premium toxin brand experience and solidify our position through rapid market entry."
vrdw88@fnnews.com Kang Jungmo Reporter